MEDIZONE INTERNATIONAL INC (MZEI) [Rocket]

Overview

MEDIZONE INTERNATIONAL INC (MZEI)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
10/19/2020	15-15D	Form 15-15D - Suspension of duty to report [Section 13 and 15(d)]:
05/11/2018	8-K	Bankruptcy or Receivership, Other Events, Financial Statements and Exhibits
04/25/2018	RW	Form RW - Registration Withdrawal Request:
04/24/2018	8-K	Termination of a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation o...
04/17/2018	DEF 14A	Form DEF 14A - Other definitive proxy statements:
04/13/2018	S-1/A	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
04/06/2018	PRE 14A	Form PRE 14A - Other preliminary proxy statements:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12	Dec-31-11	Jan-31-11
Revenues	0.0	0.2	0.2	0.0	0.4	0.2	0.0	0.1
Revenue growth	-100.0%	20.3%		-100.0%	68.7%
Cost of goods sold	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.1
Gross profit	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0
Gross margin		14.2%	41.7%		36.9%	35.8%		22.2%
Research and development	0.3	0.5	0.3	0.4	0.3	0.6	0.9	5.1
General and administrative	1.9	2.1	1.7	1.4	1.1	2.7	0.9	19.4
EBITA	-2.2	-2.5	-2.0	-1.9	-1.3	-3.3	-1.9	-26.7
EBITA margin		-1070.5%	-992.4%		-334.1%	-1459.7%		-19992.9%
Amortization of intangibles	0.1	0.1	0.1	0.0	0.0	0.0	0.0
EBIT	-2.2	-2.6	-2.0	-1.9	-1.3	-3.3	-1.9	-26.7
EBIT margin		-1094.0%	-1019.3%		-345.6%	-1475.0%		-19992.9%
Pre-tax income	-2.0	-2.7	-2.0	-1.9	-1.3	-3.3	-1.9	-26.7
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-2.0	-2.7	-2.0	-1.9	-1.3	-3.3	-1.9	-26.7
Net margin		-1128.2%	-1033.5%		-352.3%	-1486.1%		-20053.6%

Diluted EPS	($0.01)	($0.01)	($0.01)	($0.01)	$0.00	($0.01)	($0.01)
Shares outstanding (diluted)	400.2	375.1	355.5	335.7	307.9	282.0	266.1

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.